000 01385 a2200361 4500
005 20250514033344.0
264 0 _c20030123
008 200301s 0 0 eng d
022 _a1525-0016
024 7 _a10.1006/mthe.2002.0617
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEmery, David W
245 0 0 _aThe third conference on hematopoietic stem cell gene therapy: biology and technology.
_h[electronic resource]
260 _bMolecular therapy : the journal of the American Society of Gene Therapy
_cJun 2002
300 _a658-63 p.
_bdigital
500 _aPublication Type: Congress
650 0 4 _aAdenosine Deaminase
_xmetabolism
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aClinical Trials as Topic
650 0 4 _aGene Silencing
650 0 4 _aGenetic Therapy
_xtrends
650 0 4 _aGenetic Vectors
650 0 4 _aGlobins
_xgenetics
650 0 4 _aHematopoietic Stem Cell Transplantation
_xtrends
650 0 4 _aHematopoietic Stem Cells
_xphysiology
650 0 4 _aHumans
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aSevere Combined Immunodeficiency
_xtherapy
650 0 4 _aTransduction, Genetic
_xtrends
700 1 _aBodine, David M
773 0 _tMolecular therapy : the journal of the American Society of Gene Therapy
_gvol. 5
_gno. 6
_gp. 658-63
856 4 0 _uhttps://doi.org/10.1006/mthe.2002.0617
_zAvailable from publisher's website
999 _c11925173
_d11925173